{"id":"W1966067024","doi":"10.1089/apc.2007.0136","title":"Potential for New Antiretrovirals to Address Unmet Needs in the Management of HIV-1 Infection","year":2008,"lang":"en","type":"review","venue":"AIDS Patient Care and STDs","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University Health Centre","funders":"Gilead Sciences; Merck","keywords":"Raltegravir; Maraviroc; Medicine; Etravirine; Intensive care medicine; Rilpivirine; CCR5 receptor antagonist; Antiretroviral therapy; Enfuvirtide; Integrase inhibitor; Dosing; Human immunodeficiency virus (HIV); Dolutegravir; Cart; Viral load; Pharmacology; Immunology; Immune system","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008399436,0.0006408674,0.00105566,0.001520377,0.0002599155,0.00108016,0.0008205089,0.001160552,0.004424854],"category_scores_gemma":[0.001011046,0.0001898781,0.0005498195,0.001460531,0.0003670302,0.001581197,0.000683097,0.002132209,0.001547448],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005244721,"about_ca_system_score_gemma":0.001189417,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007374518,"about_ca_topic_score_gemma":0.001748988,"domain_scores_codex":[0.9997184,0.00007839817,0.00004103461,0.000034928,0.0001014322,0.00002591938],"domain_scores_gemma":[0.9995419,0.0002507397,0.00006331607,0.0000126891,0.00009812423,0.00003332303],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0000406256,0.00006225241,0.00008339314,0.01338217,0.00007359581,0.0001429318,0.00006871781,0.000315735,0.0006719882,0.004038283,0.02635053,0.9547697],"study_design_scores_gemma":[0.00002301688,0.00008264324,0.0003657058,0.005445953,0.00009195688,0.0007548305,0.00007686127,0.000093449,0.0001401347,0.002004796,0.9909079,0.00001270989],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00008089829,0.9979514,0.00009760616,0.0004959785,0.0003004429,0.000004813879,0.00001088016,0.000007833558,0.001050205],"genre_scores_gemma":[0.0004243148,0.9983513,0.0001838681,0.0003956882,0.0002169324,0.000007004647,0.00001615915,0.000001098669,0.0004036383],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004424854,"threshold_uncertainty_score":0.01480258,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02715115993716108,"score_gpt":0.3103111054010281,"score_spread":0.283159945463867,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}